Quadrant Capital Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-35
Closed -$363 2754
2024
Q3
$363 Hold
35
﹤0.01% 2678
2024
Q2
$454 Sell
35
-124
-78% -$1.61K ﹤0.01% 2635
2024
Q1
$2.78K Buy
159
+124
+354% +$2.17K ﹤0.01% 2442
2023
Q4
$330 Sell
35
-1,121
-97% -$10.6K ﹤0.01% 2646
2023
Q3
$12.9K Buy
1,156
+1,074
+1,310% +$12K ﹤0.01% 1891
2023
Q2
$1.76K Sell
82
-287
-78% -$6.14K ﹤0.01% 2437
2023
Q1
$14.9K Sell
369
-36
-9% -$1.46K ﹤0.01% 1839
2022
Q4
$18.8K Buy
405
+131
+48% +$6.09K ﹤0.01% 1688
2022
Q3
$14K Buy
274
+84
+44% +$4.29K ﹤0.01% 1724
2022
Q2
$9K Buy
190
+12
+7% +$568 ﹤0.01% 1707
2022
Q1
$13K Buy
178
+14
+9% +$1.02K ﹤0.01% 1528
2021
Q4
$12K Sell
164
-26
-14% -$1.9K ﹤0.01% 1538
2021
Q3
$11K Buy
190
+16
+9% +$926 ﹤0.01% 1528
2021
Q2
$8K Sell
174
-21
-11% -$966 ﹤0.01% 1664
2021
Q1
$10K Buy
195
+30
+18% +$1.54K ﹤0.01% 1491
2020
Q4
$7K Buy
165
+90
+120% +$3.82K ﹤0.01% 1567
2020
Q3
$3K Buy
75
+33
+79% +$1.32K ﹤0.01% 1701
2020
Q2
$2K Sell
42
-491
-92% -$23.4K ﹤0.01% 1897
2020
Q1
$28K Buy
533
+491
+1,169% +$25.8K ﹤0.01% 1140
2019
Q4
$2K Hold
42
﹤0.01% 2229
2019
Q3
$2K Hold
42
﹤0.01% 2081
2019
Q2
$3K Hold
42
﹤0.01% 2064
2019
Q1
$4K Hold
42
﹤0.01% 1910
2018
Q4
$2K Hold
42
﹤0.01% 1877
2018
Q3
$3K Hold
42
﹤0.01% 1708
2018
Q2
$4K Hold
42
﹤0.01% 1618
2018
Q1
$3K Hold
42
﹤0.01% 1695
2017
Q4
$2K Hold
42
﹤0.01% 1764
2017
Q3
$1K Hold
42
﹤0.01% 1947
2017
Q2
$0 Hold
42
﹤0.01% 1900
2017
Q1
$1K Hold
42
﹤0.01% 1780
2016
Q4
$1K Hold
42
﹤0.01% 1677
2016
Q3
$1K Buy
+42
New +$1K ﹤0.01% 1656
2016
Q1
Sell
-25
Closed 1847
2015
Q4
$0 Sell
25
-77
-75% ﹤0.01% 1604
2015
Q3
$2K Hold
102
﹤0.01% 951
2015
Q2
$4K Buy
+102
New +$4K ﹤0.01% 865